Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001214659-26-003423
Filing Date
2026-03-18
Accepted
2026-03-18 09:30:18
Documents
2
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-72527.html 3  
1 PRIMARY DOCUMENT marketforms-72527.xml 3 8584
2 POA DOCUMENT poa.htm EX-24 5519
  Complete submission text file 0001214659-26-003423.txt   15817
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF United Kingdom CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF United Kingdom CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Issuer) CIK: 0001643918 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF United Kingdom CF10 4DQ
Business Address
Stamp Stephen Anthony (Reporting) CIK: 0002111962 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37652 | Film No.: 26766223